JOHN W KOZARICH
CIK 1223000 · last filed 2026-06-09
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$12.42M
Companies
5
Total Filings
90
Lifetime Open-Market Net
-$6.46M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LGND | Director | 42,622 | $255.54 | $10.89M | -$6.63M | 73 | 2026-06-09 |
| Intec Pharma Ltd. (NTEC) Delisted | Director | 151,761 | $9.63 | $1.46M | $45.9K | 2 | 2020-07-17 |
| Travere Therapeutics, Inc. (RTRX) Delisted | Director | 29,000 | — | — | $0 | 5 | 2019-05-10 |
| QLTI | Director | 57,000 | $26.82 | $1.53M | $115.6K | 9 | 2016-06-21 |
| Corium International, Inc. (CORI) Delisted | Director | — | — | — | $0 | 1 | 2014-12-05 |
Recent Filings · Page 5 of 9
90 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2017-05-18 | Travere Therapeutics, Inc. (RTRX) Delisted | Grant (A) | +2,500 | $0 | EDGAR |
| 2016-09-09 | LGND | Exer (M) | +1,666 | $76.0K | EDGAR |
| 2016-09-09 | LGND | Sell (S) | −1,000 | -$115.0K | EDGAR |
| 2016-09-06 | LGND | Sell (S) | −1,666 | -$175.6K | EDGAR |
| 2016-08-02 | LGND | Sell (S) | −1,000 | -$137.6K | EDGAR |
| 2016-07-05 | LGND | Sell (S) | −1,000 | -$121.4K | EDGAR |
| 2016-06-21 | QLTI | Grant (A) | — | $0 | EDGAR |
| 2016-06-03 | LGND | Mixed | −1,350 | -$117.4K | EDGAR |
| 2016-05-25 | LGND | Grant (A) | +622 | $0 | EDGAR |
| 2016-05-19 | Travere Therapeutics, Inc. (RTRX) Delisted | Grant (A) | +2,000 | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.